Sort   by:  
 Page size 
UnknownQuality of life in low-risk prostate cancer under active surveillance or following radical treatments: the START cohort study.

Background

Real-world evidence on quality of life (QoL) changes associated with treatment decisions is crucial for informed choices by patients with low-risk prostate cancer (LRPC).

Methods

A prospective cohort study was conducted in the Piemonte and Valle d'Aosta Regional Oncology Ne...
S-EPMC12909112 | biostudies-literature
UnknownThe Role of Rituximab in Primary Focal Segmental Glomerular Sclerosis of the Adult

Introduction

Primary focal segmental glomerular sclerosis (FSGS) is a rare, likely immune-mediated disease. Rituximab (RTX) may play a role in management, although data in adults are scanty.

Methods

We collected cases of RTX-treated primary FSGS within the Italian Society of Nephro...
S-EPMC9366368 | biostudies-literature
UnknownComparison of the Effectiveness of Three Different Acupuncture Methods for TMD-Related Pain: A Randomized Clinical Study.

Purpose

This study aimed to compare the effectiveness of three acupuncture methods for temporomandibular disorders- (TMDs-) related pain.

Materials and methods

Different locations of pain, according to DC/TMD clinical assessment, were considered: temporomandibular joint (TMJ), mastica...
S-EPMC8632462 | biostudies-literature
UnknownEnhanced recovery after bariatric surgery: a comprehensive survey-based analysis of ERABS actual clinical implementation in Italian bariatric centers.
The escalating global prevalence of bariatric procedures necessitates an enhanced focus on optimizing perioperative care for improved patient outcomes. This study focuses on the implementation of Enhanced Recovery After Bariatric Surgery (ERABS) protocols in Italian bariatric centers to optimize per...
S-EPMC12540566 | biostudies-literature
UnknownExtracellular vesicles miR-574-5p and miR-181a-5p as prognostic markers in NSCLC patients treated with nivolumab.
Immune checkpoint inhibitors (ICIs) have revolutionized the management of advanced non-small cell lung cancer (NSCLC), although patient survival is still unsatisfactory. Accurate predictive markers capable of personalizing the treatment of patients with NSCLC are still lacking. Circulating extracell...
S-EPMC11303437 | biostudies-literature
UnknownOriganum majorana Extracts: A Preliminary Comparative Study on Phytochemical Profiles and Bioactive Properties of Valuable Fraction and By-Product
Not available
S-EPMC12348732 | biostudies-literature
UnknownEffects of COVID-19 Lockdown on Adherence to Individual Home- or Gym-Based Exercise Training among Women with Postmenopausal Osteoporosis.
Adherence is important for an exercise program's efficacy. This study aims at investigating whether the COVID-19 lockdown had different consequences on the adherence to an exercise program specifically designed for women with postmenopausal osteoporosis when administered as individual home training ...
S-EPMC7967569 | biostudies-literature
UnknownImmune checkpoint inhibitor associated vitiligo and its impact on survival in patients with metastatic melanoma: an Italian Melanoma Intergroup study.

Background

Checkpoint inhibitors in melanoma can lead to self-immune side-effects such as vitiligo-like depigmentation (VLD). Beyond the reported association with favorable prognosis, there are limited data regarding VLD patient features and their echo on the therapeutic outcomes.

Methods...

S-EPMC7970061 | biostudies-literature
UnknownMore Favorable Short and Long-Term Outcomes for Screen-Detected Colorectal Cancer Patients.

Background

Screening significantly reduces mortality from colorectal cancer (CRC). Screen detected (SD) tumors associate with better prognosis, even at later stage, compared to non-screen detected (NSD) tumors. We aimed to evaluate the association between diagnostic modality (SD vs. NSD) and...
S-EPMC8005726 | biostudies-literature
UnknownThe density and spatial tissue distribution of CD8+ and CD163+ immune cells predict response and outcome in melanoma patients receiving MAPK inhibitors.

Background

Clinical response to MAPK inhibitors in metastatic melanoma patients is heterogeneous for reasons still needing to be elucidated. As the patient immune activity contributes to treatment clinical benefit, the pre-existing level of immunity at tumor site may provide biomarkers of di...
S-EPMC6858711 | biostudies-literature
Sort   by:  
 Page size